Lynn Hunt, from the UK, Initially thought she had just ‘bitten’ her tongue when two little white spots appeared on the side, ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

Yanghee Woo, MD, discusses the details and lasting impact of the CROSS trial in the treatment of gastroesophageal junction ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, ...

In a report released yesterday, Yigal Nochomovitz from Citi maintained a Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report), ...

Dr Muneeb Shah noticed something unusual on his chest, and his suspicions of basal cell skin cancer were correct ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally adv ...

In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made tumors more amenable to surgery, which was associated with ...

Cells in the head and neck are especially vulnerable to air pollution, including tobacco smoke, which contains numerous ...

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future ...